Latest News about ASND
Recent news which mentions ASND
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
May 15, 2024
From Benzinga
From Benzinga
Tickers
ASND
From InvestorPlace
From Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
April 03, 2024
From Benzinga
From Benzinga
These Five Small-Cap Stocks Under The Radar Are Expected To Surge, Says Stock Researcher
March 03, 2024
From Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $45,000 Today
February 23, 2024
From Benzinga
From Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
From Benzinga
From Benzinga
Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial
December 19, 2023
Tickers
ASND
From Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
September 28, 2023
From Benzinga
Earnings Scheduled For September 5, 2023
September 05, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.